Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study that ...
Please provide your email address to receive an email when new articles are posted on . Women with type 2 diabetes who are at risk for heart disease had a 30% reduction in adverse cardiovascular ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Fenofibrate 67mg, 134mg, 200mg; caps (micronized). Adjunct to diet: in severe hypertriglyceridemia; and to reduce elevated total-C, LDL-C, ApoB, and TG, and to increase HDL-C in primary hyperlipidemia ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that the blood-fat lowering drug fenofibrate is as effective in women with type 2 ...
kidney cross section Researchers assessed the incidence and potential risk factors for the development of fenofibrate-associated nephrotoxicity in patients with gout. Fenofibrate-associated ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with type 2 diabetes had a 36% lower risk for ...
Fenofibrate Found Safe in Diabetes With Renal Impairment Long-term daily use of fenofibrate is beneficial for patients with type 2 diabetes and moderate renal impairment and is not associated with an ...
Treatment with fenofibrate in individuals with type 2 diabetes mellitus reduces the need for laser treatment for diabetic retinopathy (DR), conclude authors of an Article published early Online and in ...
The effects of combined fibrate and statin treatment (simvastatin 10mg plus fenofibrate 200mg) on plasma lipid and lipoprotein (TC, TG, LDL-C, HDL-C) levels at baseline and after 3, 6 and 12 months, ...